APPLIED DNA SCIENCES INC Quarterly Common Stock, Shares Authorized from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Applied Dna Sciences Inc quarterly Common Stock, Shares Authorized history and growth rate from Q3 2010 to Q2 2024.
  • Applied Dna Sciences Inc Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 200M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 200M 0 0% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 200M 0 0% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 200M 0 0% Sep 30, 2023 10-Q 2024-08-08
Q2 2023 200M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 200M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 200M 0 0% Dec 31, 2022 10-Q 2023-02-09
Q3 2022 200M 0 0% Sep 30, 2022 10-K 2023-12-07
Q2 2022 200M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 200M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 200M 0 0% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 200M 0 0% Sep 30, 2021 10-K 2022-12-14
Q2 2021 200M -300M -60% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 200M -300M -60% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 200M -300M -60% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 200M -300M -60% Sep 30, 2020 10-K/A 2021-12-14
Q2 2020 500M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 500M 0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 500M 0 0% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 500M 0 0% Sep 30, 2019 10-K 2020-12-17
Q2 2019 500M 0 0% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 500M 0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 500M 0 0% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 500M 0 0% Sep 30, 2018 10-K 2019-12-12
Q2 2018 500M 0 0% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 500M 0 0% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 500M 0 0% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 500M 0 0% Sep 30, 2017 10-K 2018-12-18
Q2 2017 500M 0 0% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 500M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 500M 0 0% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 500M 0 0% Sep 30, 2016 10-K 2017-12-28
Q2 2016 500M 0 0% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 500M 0 0% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 500M 0 0% Dec 31, 2015 10-Q 2016-02-10
Q3 2015 500M -850M -63% Sep 30, 2015 10-K 2016-12-06
Q2 2015 500M -850M -63% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 500M -850M -63% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 500M -850M -63% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 1.35B 0 0% Sep 30, 2014 10-K 2015-12-14
Q2 2014 1.35B 0 0% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 1.35B 0 0% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 1.35B 0 0% Dec 31, 2013 10-Q/A 2014-05-02
Q3 2013 1.35B 0 0% Sep 30, 2013 10-K 2014-12-15
Q2 2013 1.35B 0 0% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 1.35B 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 1.35B +550M +68.8% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 1.35B +550M +68.8% Sep 30, 2012 10-K/A 2014-05-01
Q2 2012 1.35B +550M +68.8% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 1.35B Mar 31, 2012 10-Q 2012-05-15
Q4 2011 800M Dec 31, 2011 10-Q 2013-05-15
Q3 2011 800M 0 0% Sep 30, 2011 10-K 2012-12-20
Q2 2011 800M Jun 30, 2011 10-Q 2011-08-10
Q3 2010 800M Sep 30, 2010 10-K 2011-12-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.